日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Evaluating Long-Term Effectiveness of Cystic Fibrosis Modulator Therapies after Rapid Adoption: A Dual-Approach Study

快速推广应用后评估囊性纤维化调节剂疗法的长期疗效:一项双重方法研究

Miranda Afonso, Pedro; Zhou, Grace C; Su, Weiji; Burgel, Pierre-Régis; Cromwell, Elizabeth; Goss, Christopher H; Keogh, Ruth H; Liou, Theodore G; Marshall, Bruce C; Mayer-Hamblett, Nicole; Morgan, Wayne J; Ostrenga, Joshua S; Pasta, David J; Schechter, Michael S; Stanojevic, Sanja; Wainwright, Claire E; Szczesniak, Rhonda D; Andrinopoulou, Eleni-Rosalina

Outcomes of the Navajo Community Asthma Program during the COVID-19 pandemic

纳瓦霍社区哮喘项目在新冠疫情期间的成果

Bender, Bruce G; Begay, Elvira; Crooks, James; Gerald, Joe K; Hudson, Bryan; King, Diane K; Kobernick, Aaron; Liu, Andrew H; Lowe, Ashley A; Morgan, Wayne; Nez, Peter; Phan, Hanna; Tso, Buffy; Wightman, Patrick; Gerald, Lynn B

Evaluating the Impact of the COVID-19 Pandemic on Pediatric Asthma Incidence

评估新冠肺炎疫情对儿童哮喘发病率的影响

Devonshire, Ashley L; Guilbert, Theresa; Bauer, Cindy S; Schmidt, Heidi; Davis, Stephanie; Hernandez, Michelle; Fitzpatrick, Anne M; Gaffin, Jonathan M; Kattan, Meyer; De, Aliva; Jackson, Daniel J; Mauger, David; Phipatanakul, Wanda; Schwartz, Justin T; Sheehan, William; Long, Dayna; Juarez, Lourdes; Bacharier, Leonard B; Stokes, Jeffrey R; Teach, Stephen J; Morgan, Wayne J; Martinez, Fernando D

Factors associated with prescription of elexacaftor/tezacaftor/ivacaftor among people with cystic fibrosis aged 12 years or older with at least one F508del allele

囊性纤维化患者(12岁及以上,至少携带一个F508del等位基因)使用依来沙卡托/替扎沙卡托/伊伐卡托的相关因素

Hergenroeder, Georgene E; Todd, Jonathan V; Ostrenga, Josh S; Goss, Christopher H; Jain, Raksha; Morgan, Wayne; Sawicki, Gregory S; Schechter, Michael S; Cromwell, Elizabeth A; Ren, Clement L

Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del variant in the USA

在美国,扩大依来卡托/替扎卡托/伊伐卡托适应症对不伴有F508del变异的囊性纤维化患者的影响

Cromwell, Elizabeth A; Ostrenga, Josh S; Sanders, Don B; Morgan, Wayne; Castellani, Carlo; Szczesniak, Rhonda; Burgel, Pierre-Regis

Additional Thoughts on Intrinsic Dysanapsis

关于内在发育不良的补充思考

Tepper, Robert S; Morgan, Wayne J; Taussig, Lynn M

Circulating biomarkers of airflow limitation across the life span

生命周期中气流受限的循环生物标志物

Zhai, Jing; Voraphani, Nipasiri; Imboden, Medea; Keidel, Dirk; Liu, Congjian; Stern, Debra A; Venker, Claire; Petersen, Hans; Bosco, Anthony; Sherrill, Duane L; Morgan, Wayne J; Tesfaigzi, Yohannes; Probst-Hensch, Nicole M; Martinez, Fernando D; Halonen, Marilyn; Guerra, Stefano

Childhood asthma exacerbations on the Navajo Nation

纳瓦霍族地区的儿童哮喘急性发作

Bender, Bruce G; Crooks, James; Gerald, Joe K; Hudson, Bryan; King, Diane K; Kobernick, Aaron; Liu, Andrew H; Lowe, Ashley A; Morgan, Wayne; Nez, Peter; Phan, Hanna; Wightman, Patrick; Gerald, Lynn B

Treatment of small as well as large declines in lung function enhances recovery to baseline in people with CF

对于囊性纤维化患者,无论肺功能下降幅度大小,治疗均有助于其恢复至基线水平。

Schechter, Michael S; Ostrenga, Joshua S; Cromwell, Elizabeth A; Ren, Clement L; Fink, Aliza K; Sanders, D B; Morgan, Wayne J

Elevated Childhood Insulin-related Asthma Is a Risk Factor for Reduced Lung Function

儿童时期胰岛素相关性哮喘是肺功能下降的危险因素

Carr, Tara F; Stern, Debra A; Morgan, Wayne; Guerra, Stefano; Martinez, Fernando D